4basebio PLC (88Q.DE) XETRA

6.15

-0.85(-12.14%)

Updated at June 02 05:35PM

Currency In EUR

Valuation

Market Cap90.64M
Enterprise Value89.34M
P/E Ratio-5.06
PEG Ratio0.4
Price/Sales Ratio50.31
Price/Book Ratio8.45
Enterprise/Revenue49.54
Enterprise/EBITDA-5.53

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-9.99
Operating Margin-9.88

Management Effectiveness

Return On Assets-0.57
Return On Equity-1.16

Income Statement

Revenue1.69M
Revenue/Share0.11
Gross Profit548,348
EBITDA-15.59M
Net Income-16.92M
Diluted EPS-1.09

Balance Sheet

Total Cash17.81M
Total Cash/Share1.15
Total Debt16.52M
Total Debt/Equity1.63
Current Ratio7.31
Book Value Per Share0.65

Price History

52-Week Change-53.41
52-Week High13.2
52-Week Low4.64
Moving Average 50 Days5.6
Moving Average 200 Days7.18

Statistics

Average Volume473
Shares Outstanding15.48M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A